Open AccessTargeting MYCN and ALK in resistant and relapsing neuroblastoma
Author(s) -
Elizabeth R. Tucker,
Evon Poon,
Louis Chesler
Publication year - 2019
Language(s) - English
DOI - 10.20517/cdr.2019.009
Subject(s) - neuroblastoma , anaplastic lymphoma kinase , cancer research , crizotinib , medicine , targeted therapy , oncogene , alk inhibitor , disease , oncology , biology , cancer , lung cancer , genetics , cell cycle , cell culture , malignant pleural effusion